Fortune Brands Innovations (FBIN)
NYSEIndustrialsConstruction MaterialsSnapshot 2026-09-04
NYSEIndustrialsConstruction MaterialsSnapshot 2026-09-04
Warn: Primary pillar under pressure — Operating margin recovers toward 11% by FY26 end: TTM operating margin 6.8% vs 11% target.
Fortune Brands has a new CEO to improve the company. Free cash flow should reach about $375 million in 2026. The company keeps capital spending between $110 million and $125 million. Demand trends support steady sales despite recent declines.
Sales have fallen about 2% recently and may keep falling. Profit margins dropped from 11.3% to 6% in one quarter. Earnings per share guidance was lowered to about $3.15 for 2026. Leadership changes may not fix problems quickly.
The price is about 12% above our fair value near $46. Analysts expect only about 1% revenue growth. Our view sees risks in growth and profit margins.
Breaks if: Capex exceeds $130 million in FY26
Management commits to disciplined capital spending within guided range to support operational needs and strategic investments.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a turnaround story with a focus on improving execution and profitability. The current thesis state is cautious, as the company faces headwinds in its sector and has shown mixed financial results recently.
The market appears to price in a low level of fragility due to weak execution quality, but not the full extent of challenges the company faces. Valuation is considered cheap compared to peers, indicating that expectations may be lower than for other companies in the sector.
Fundamentals may show limited progress as management continues to emphasize execution and profitability improvement. Recent financial performance has been neutral, with some operational improvements noted, but overall results remain below industry peers.
The long-term thesis hinges on management's ability to improve execution and profitability while navigating sector challenges. Key scenarios include the performance of sector bellwethers and the potential impact of guidance cuts on market expectations.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improvement. Additionally, the board restructuring aligns with a strengthening management team objective. There are no new threats impacting the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 3 of last 3 quarters. Management has consistently maintained 2026 capex guidance in the range of $110M to $125M, reflecting disciplined capital allocation. This guidance has remained stable despite external uncertainties, indicating delivery on capital discipline commitments.
“Capex $110 million to $125 million for 2026, consistent with prior guidance.”
“Capex $110 million to $125 million for 2026, reflecting disciplined capital allocation.”
“Capex $110 million to $140 million for 2026, reflecting measured planning approach.”
Breaks if: Free cash flow falls below $350 million in FY26
Management commits to disciplined capital spending within guided range to support operational needs and strategic investments.
Stated as a priority in 3 of last 3 quarters. Management has consistently maintained 2026 capex guidance in the range of $110M to $125M, reflecting disciplined capital allocation. This guidance has remained stable despite external uncertainties, indicating delivery on capital discipline commitments.
“Capex $110 million to $125 million for 2026, consistent with prior guidance.”
“Capex $110 million to $125 million for 2026, reflecting disciplined capital allocation.”
“Capex $110 million to $140 million for 2026, reflecting measured planning approach.”
Breaks if: No progress in leadership or strategy by end 2026
Company is undergoing CEO transition and management strengthening to support strategic execution and operational improvement.
Stated as a priority in 3 of last 3 quarters. The company has undergone significant leadership changes including appointment of Jesse Singh as CEO in June 2026, interim CEO David Barry named COO, and interim CFO Ashley George continuing. These changes reflect management's focus on strengthening leadership to support execution. The priority is actively addressed with recent appointments.
“CEO Jesse Singh appointed June 29, 2026; Interim CEO David Barry named COO.”
“Interim CEO David Barry leading; Interim CFO Ashley George appointed.”
“Board launched CEO search; Amit Banati stepped down; Ed Garden appointed to Board.”
Breaks if: Operating margin stays below 8% through FY26
Management is focused on enhancing operating income and margins through cost discipline, restructuring, and efficiency improvements.
Stated as a priority in 3 of last 3 quarters. GAAP operating income declined sharply from $171.6M in 2025-Q2 to -$9.0M in 2026-Q2, impacted by charges. However, operating income before charges/gains increased 18.4% year-over-year to $235.6M in 2026-Q2. Management continues to emphasize cost discipline and profitability improvement, with mixed financial results reflecting ongoing restructuring and investments.
“CEO Singh: 'We bring greater discipline to our cost base... Our updated guidance reflects investments to execute on these opportunities.'”
“Interim CEO Barry: 'Our teams are responding by taking action across the entire P&L to offset headwinds and enhance profitability.'”
“CFO Baksht: 'We are identifying further opportunities to structurally improve our performance and return the business to expected profitability.'”
Breaks if: Revenue falls below $4.3 billion in FY26
Continue efforts to grow sales across key brands and markets despite challenging external environment.
In the next 1 to 3 years, FBIN's performance will depend on its execution and the broader industrial sector's health. Not investment advice.